Blog
RSS FeedPosted by Michael Wonder on 28 Feb 2021
New Zealand Pharmaceutical Schedule - 1 March 2021
1 March 2021 - The March 2021 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 25 Feb 2021
Multiple sclerosis treatments
25 February 2021 - From 1 March 2021, more people will be able to access multiple sclerosis treatments for longer. ...
Posted by Michael Wonder on 24 Feb 2021
PHARMAC knew of epilepsy drug change risks - inquest
24 February 2021 - PHARMAC knew there were clinical reasons some epilepsy patients would not tolerate a change to their ...
Posted by Michael Wonder on 24 Feb 2021
PHARMAC knew of epilepsy drug change risks within some patients, but went ahead with switch
24 February 2021 - PHARMAC knew there were clinical reasons some epilepsy patients would not tolerate a change to their medicines. ...
Posted by Michael Wonder on 23 Feb 2021
Epilepsy drug deaths: Medsafe told PHARMAC it was 'not desirable' to switch brands
23 February 2021 - The medicines safety authority advised PHARMAC it was “not desirable” for patients to switch brands of ...
Posted by Michael Wonder on 22 Feb 2021
Maker of epilepsy drug warned over quality control
23 February 2021 - The drug at the centre of an inquest into six epilepsy deaths was made at a plant ...
Posted by Michael Wonder on 21 Feb 2021
Epilepsy drug deaths: Coronial inquiry into medication-linked deaths resumes
22 February 2021 - A coronial inquiry into the deaths of six patients whose epilepsy medication was changed before they ...
Posted by Michael Wonder on 17 Feb 2021
Supplier of expensive cystic fibrosis medication yet to apply for PHARMAC approval
17 February 2021 - Government drug-buying agency PHARMAC has revealed the supplier of expensive cystic fibrosis medicine Trikafta still hasn’t ...
Posted by Michael Wonder on 15 Feb 2021
The price of a life: stark choice facing Kiwis needing unfunded medicines
16 February 2021 - Sick New Zealanders who need unfunded medicines are faced with a stark choice: turn to crowdfunding ...
Posted by Michael Wonder on 12 Feb 2021
PHARMAC widens access to funded treatments for multiple sclerosis
12 February 2021 - PHARMAC announced today that it will be widening access to all funded multiple sclerosis treatments from 1 ...
Posted by Michael Wonder on 09 Feb 2021
Teen thriving on PHARMAC funded medicine
9 February 2021 - 14 year old Bruno Cettina is living his best life thanks to a medicine funded by PHARMAC. ...
Posted by Michael Wonder on 07 Feb 2021
Timaru mother with terminal bowel cancer calling on Government to fund cetuximab
5 February 2020 - A terminally ill woman shelling out more than $12,000 a year for extra time with her ...
Posted by Michael Wonder on 03 Feb 2021
Cystic fibrosis survivor calls for life-saving drug Trikafta to be funded as PHARMAC dangles hope
3 February 2021 - Drug buying agency PHARMAC has revealed it is willing to go directly to the Government for ...
Posted by Michael Wonder on 03 Feb 2021
First COVID-19 vaccine approved for NZ: How did we get here and what comes next
3 February 2021 - The medicines safety authority has approved the first COVID-19 vaccine for use in New Zealand. ...
Posted by Michael Wonder on 02 Feb 2021
Cystic fibrosis sufferer Bella Powell hits out at drug company for stalling PHARMAC funding
2 February 2021 - A cystic fibrosis patient is calling out American drug company Vertex, for not achieving PHARMAC funding. ...